secwatch.observer — SEC 8-K summary
======================================

Issuer:     CalciMedica, Inc. (CALC)
CIK:        0001534133
Form:       8-K
Filed at:   2022-04-18T23:59:59+00:00
Accession:  0001564590-22-014650
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Graybug Vision appoints Dirk Sauer to board; Gerald Cagle resigns as director
-----------------------------------------------------------------------------

- Gerald Cagle resigned as director and from Nominating and Governance Committee effective April 13, 2022; will remain as paid advisor.
- Dirk Sauer appointed to board to fill vacancy, will serve as Class I director, expected to stand for election at 2024 annual meeting.
- Sauer will chair newly formed Science and Innovation Committee; compensation includes $40k annual retainer, $4k committee fee, and 80,000 share option grant vesting over 3 years.
- Sauer brings 30+ years ophthalmic drug development experience, previously led Novartis Ophthalmology Development Unit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534133/000156459022014650/0001564590-22-014650-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534133/000156459022014650/gray-8k_20220413.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-014650

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer